Oral administration of polymyxin to specific-pathogen-free C3H/Law mice which were previously contaminated with gram-negative bacteria resulted in complete suppression of cecal gram-negative bacteria. Suppression of cecal gram-negative bacteria was accompanied by reduction of the cecal endotoxin concentration from 10 to 1 ,ug/g of cecal content as measured with a microtechnique for the Limulus amebocyte lysate assay. Endotoxin determination by this assay appeared to be unaffected by the amount of polymyxin present in cecal preparations after oral administration of this antibiotic. In experimentally contaminated specificpathogen-free mice, the femoral concentration of progenitor cells forming granulocyte-macrophage colonies in vitro (CFU-GM) decreased significantly (P < 0.001) to 66% of the initial control after 4 days of polymyxin treatment. However, the femoral CFU-GM concentration in germfree mice and splenic CFU-GM concentration in experimentally contaminated specific-pathogen-free and germfree mice was not affected by polymyxin treatment. The kinetic behavior of femoral and splenic CFU-GM in experimentally contaminated specificpathogen-free and germfree mice was expressed as the in vivo sensitivity to the S-phase-specific cytostatic drug hydroxyurea, i.e., the hydroxyurea kill. Administration of polymyxin to experimentally contaminated specific-pathogen-free mice significantly diminished the hydroxyurea kill of femoral CFU-GM from 29 to 13% (P < 0.02) and of splenic CFU-GM from 53 to 27% (P < 0.005). The hydroxyurea kill of femoral CFU-GM in germfree mice was not significantly affected by polymyxin treatment. On basis of these results we conclude that the effect of polymyxin treatment on myelopoiesis is most likely due to elimination of intestinal gram-negative bacteria and may indicate a significant role of intestinal gram-negative bacteria in the regulation of myelopoiesis.
The microbial composition of the intestinal microflora, particularly (aerobic) gram-negative bacteria (GNB), appears to be of importance in myelopoiesis. Alterations of the level of intestinal GNB either by administration of antibiotics (21; H. Goris, S. Daenen, D. van der Waaij, and M. R. Halie, Exp. Hematol. 12:382, 1984) or by association of germfree (GF) animals with GNB (6, 18) have been shown to affect myelopoiesis. These observations argue for a role of intestinal GNB in the regulation of myelopoiesis. Injection of endotoxin, a cell wall component of GNB, is known to influence hemopoiesis at the stem cell level (1, 9, 29) . Since endotoxin is released by GNB into the surrounding medium (17, 27) , myelopoiesis is supposed to be affected by leakage of endotoxin through the mucosa of the intestinal tract (5, 11, 16) . It has been suggested that myelopoiesis is regulated by the host's own microflora via intermittent endotoxemia (25) .
Selective elimination of GNB from the intestinal tract of C3H/Law mice by oral administration of the nonabsorbable drug polymyxin (14, 32) has been shown to reduce the fecal ("free") endotoxin concentration (H. Goris, F. de Boer, and D. van der Waaij, Scand. J. Infect. Dis., in press) and to affect hemopoietic stem cell kinetics at different stages (Goris et al., Exp. Hematol. 12:382, 1984) .
To establish the involvement and contribution of the intestinal microflora, particularly GNB, in the regulation of myelopoiesis, experimentally contaminated specificpathogen-free (EC-SPF) and GF C3H/Law mice were orally treated with polymyxin. In both types of mice the effect of polymyxin treatment on the cecal level of GNB, polymyxin, endotoxin, and level of bone marrow and splenic progenitor cells forming granulocyte-macrophage colonies in vitro (CFU-GM) was established. Interference of polymyxin with endotoxin determination in cecal supernatants by the Limulius amebocyte lysate (LAL) assay (12, 19) was estimated by incubation of cecal supernatants of untreated control mice with polymyxin. The kinetics of bone marrow and splenic CFU-GM were followed by determination of the susceptibility of these progenitor cells to the S-phase-specific cytostatic drug hydroxyurea (HU).
MATERIALS AND METHODS
Mice. Specific-pathogen-free (SPF) and GF female C3H/Law mice between 8 and 12 weeks of age and weighing 20 to 25 g were used.
Housing. The SPF mice were kept three per cage in a conventional animal room and fed ad libitum with sterilized pelleted food (Hope Farms, The Netherlands) and autoclaved water. The GF mice were maintained in plastic germfree isolators (positive pressure isolator 1020; Metall & Plastic GmbH, Radolfzell, Federal Republic of Germany).
Contamination. To prevent variability in the level and occurrence of intestinal GNB, all SPF animals were orally contaminated with 10 FLl of a 10-fold dilution in saline of overnight cultures of Escherichia coli (API profile 5144572), Enterobacter cloacae (API profile 3305573), and Klebsiella pneumoniae (API profile 5205773) in brain heart infusion broth (Difco Laboratories, Detroit, Mich.). Each SPF mouse received a mixture of approximately 106 bacteria of each of these bacterial strains, which were isolated from the feces of Biotyping of aerobic GNB. After subculturing, pure cultures were made of the aerobic GNB. They were identified with the API 20E system (API Benelux b.v., The Netherlands) (4, 24) .
Preparation of cecal supernatants. Cecal supernatants were prepared by centrifugation (5,000 x g, 10 min, 0 to 4°C) of cecal suspensions in pyrogen-free saline (1:4, wt/vol).
Determination of cecal endotoxin concentration. The cecal endotoxin concentration was estimated by a modification (Goris et al., in press) of a microtechnique (12) 10 -fold serial dilutions were made in pyrogenfree saline and tested in duplicate for the highest dilution step that still caused gel formation. The endotoxin concentration of a sample was calculated by multiplying the sensitivity of the LAL assay, as tested by 10-fold serial dilution of a reference solution of endotoxin (Mallinckrodt), by the reciprocal of the highest positive dilution of a sample.
Determination of the cecal polymyxin concentration. The concentration of polymyxin was estimated by the method of Goss and Cimijotti (13 10' M P-mercaptoethanol (Merck), 1% bovine serum albumin (GIBCO), 100 U of penicillin per ml, and 100 ,ug of streptomycin per ml. Furthermore, an optimal amount of 10 plI of a pokeweed mitogen-stimulated spleen cell-conditioned medium (3) per ml of culture medium was added to provide the system with factor(s) essential for colony growth. Cellular aggregates consisting of 50 or more cells were scored as colonies by using an inverted microscope. For each experimental point four replicate cultures were counted. In all of the harvested colonies, macrophages, granulocytes, or both were found after staining with May-Grunwald-Giemsa.
Determination of the HU kill. At day 0 and day 4 of polymyxin treatment, groups of three animals were injected intravenously with 900 mg of HU (Sigma Chemical Co., St. Louis, Mo.) per kg of body weight (injection volume, 0.25 ml per 20 g of body weight) in pyrogen-free saline 2 h before sacrifice (26) . The corresponding control group of three mice was injected with pyrogen-free saline. The HU kill of femoral and splenic CFU-GM, i.e., the difference in concentration between the saline and HU groups, was expressed as a percentage of the saline control during corresponding periods of polymyxin treatment.
Statistical evaluations. The mean and the standard error of the mean were calculated. A two-tailed Student t-test was used for comparison of two means. The level of significance was set at P = 0.05.
RESULTS
Cecal concentration of aerobic GNB, endotoxin, and polymyxin. Before oral administration of polymyxin to EC-SPF mice, 104 to 106 E. coli orgatnisms, 104 to 106 Enterobacter cloacae organisms, and 102 to 104 Klebsiella pneumoniae organisms were cultured per gram of cecal content. After 4 days of polymyxin treatment, aerobic GNB were found completely suppressed (<102 bacteria per g of cecal content) ( Table 1) . From the cecal contents of GF mice no aerobic GNB were cultured before and after polymyxin treatment. Before initiation of polymyxin treatment the cecal endotoxin concentration of EC-SPF mice was found to be 100 times higher than the endotoxin concentration in the cecal content of GF mice before initiation of polymyxin treatment. No difference was observed between the cecal endotoxin concentration in SPF and EC-SPF mice. Suppression of aerobic GNB in EC-SPF mice by oral administration of polymyxin was accompanied by a reduction of the cecal endotoxin concentration from 10 to 1 ,ug/g of cecal content. In GF mice polymyxin treatment did not affect the low cecal endotoxin concentration. Despite the similarity in daily intake of polymyxin (3 to 4 ml/day per mouse) by EC-SPF and GF mice, the cecal concentration after 4 days of treatment in EC-SPF mice was found to be significantly (P < 0.05) higher than the cecal concentration in GF mice.
Polymyxin and endotoxin concentration in cecal supernatants after incubation. After incubation of cecal supernatants of untreated EC-SPF and GF mice with different amounts of polymyxin, a significant reduction of the polymyxin concentration was observed (Table 2) . From cecal supernatants of GF mice 2 to 3 times more polymyxin was recovered than from cecal supernatants of EC-SPF mice. Polymyxin concentrations established after incubation of cecal supernatants of EC-SPF and GF mice with this antibiotic, which were similar to the polymyxin concentration after oral administration (Table 1) Comparison of corresponding data for the femoral CFU-GM concentration of EC-SPF and GF mice revealed a significant difference (P < 0.01) at day 0 of polymyxin treatment for the saline control. Only in EC-SPF mice both the S-phase and non-Sphase fraction were decreased by oral administration of polymyxin. The susceptibility of femoral CFU-GM to HU in EC-SPF mice during polymyxin treatment, i.e., the decrease of the S-phase fraction, was reflected by a significant decrease (P < 0.02) of the HU kill from 29 to 13%. However, the HU kill of GF mice was not significantly affected by polymyxin treatment.
Obviously, oral administration of polymyxin to EC-SPF mice during a period of 4 days reduced the HU kill of femoral CFU-GM to a level which was similar to the level in GF mice.
Splenic nucleated cell content, CFU-GM concentration, and HU kill. The splenic nucleated cell content of EC-SPF and GF mice was not affected by oral polymyxin treatment and injection of HU (Table 4 ). The spleens of EC-SPF mice contained 2 to 5 times more CFU-GM (total and non-Sphase) than did the spleens of GF mice. Polymyxin treatment of EC-SPF and GF mice for 4 days did not affect the splenic CFU-GM concentration of the saline control. However, the CFU-GM concentration in EC-SPF mice after HU injection, i.e., the non-S-phase fraction, increased significantly (P < 0.001) from 87 to 130 CFU-GM per 5 x 105 nucleated cells after 4 days of polymyxin treatment.
Before initiation of polymyxin treatment the splenic CFU- GM pool in GF mice was found to be less susceptible to HU than that in EC-SPF mice; the HU kill was 14 and 53%, respectively. The S-phase fraction of splenic CFU-GM in EC-SPF mice, presented as the HU kill, was decreased significantly (P < 0.005) by polymyxin treatment. In contrast to the effect of polymyxin on the HU kill of splenic CFU-GM in EC-SPF mice, in GF mice the HU kill of CFU-GM increased significantly (P < 0.05) from 14 to 28%. DISCUSSION The significance of the intestinal microflora in relation to myelopoiesis was demonstrated by comparison of the level and HU kill of myelopoietic progenitor cells (CFU-GM) in the bone marrow and spleen of EC-SPF and GF C3H/Law mice. The EC-SPF mice resembled clean conventional (i.e., pathogen-free) mice with respect to level and occurence of GNB. However, in comparison with conventional mice, from which Proteus and Pseudomonas species can be often isolated (28) , pathogens were absent.
The absence of the intestinal microflora in GF mice was associated with a reduction of the level and HU kill of both bone marrow and splenic CFU-GM. Regarding the difference in CFU-GM level between EC-SPF and GF mice, a reduced level has also been reported for GF CBA mice (6, 21) . In Swiss mice, on the other hand, no difference was observed between conventional and GF mice (2, 22, 23) . This may indicate the mouse strain dependency of this phenomenon.
In the present study, however, polymyxin treatment of EC-SPF mice caused reduction of the number of bone marrow CFU-GM level and HU kill to a level similar to the level in GF mice. In contrast, in GF mice, bone marrow and splenic myelopoiesis was not affected by polymyxin treatment, with the exception of the HU kill of splenic CFU-GM. The increase of the HU kill of splenic CFU-GM in the GF mice during polymyxin treatment was most probably aspecific and may be due to stress. The GF mice were transferred into a laminar-air-flow bank just before polymyxin treatment. Nevertheless, polymyxin-induced alterations of myelopoiesis in EC-SPF mice were not accompanied by similar (parallel) alterations in GF mice. Therefore, the effect of polymyxin treatment on myelopoiesis in EC-SPF mice was most likely mediated by the intestinal flora.
The involvement of the intestinal microflora in canine granulopoiesis has also been observed in dogs after oral administration of a broad-spectrum gut-sterilizing combination of bacitracin and neomycin (20, 31) . In contrast to polymyxin treatment, however, this antimicrobial regimen was not selective for GNB (31) . Since polymyxin treatment has been shown to cause selective elimination of intestinal GNB in conventional mice (10, 14) , polymyxin-induced alterations in myelopoiesis may be ascribed to the role (i.e., contribution) of intestinal GNB in myelopoiesis.
Selective elimination of GNB by polymyxin treatment was accompanied by a reduction of the cecal endotoxin concentration to 10% of the initial (normal) value. Reduction of the cecal endotoxin level cannot be ascribed to inactivation of endotoxin (7, 8, 30) or inhibition of the LAL assay by the presence of polymyxin in cecal supernatants after oral administration. The present study has shown that cecal polymyxin levels similar to the level after oral administration do not interfere with endotoxin determination in cecal supernatants by the LAL assay. Therefore, reduction of the cecal endotoxin concentration by polymyxin treatment should be due to elimination of the major source (i.e., GNB) of cecal endotoxin.
The rather low contribution of GNB to the total bacterial counts (106 GNB versus 1011 total bacteria per g of feces [28] ) in the intestinal tract of EC-SPF mice was inversely related to the substantial contribution of these bacteria in the regulation of myelopoiesis. Moreover, myelopoiesis has been shown to be influenced by injection of endotoxin or structurally related cell wall components of GNB (1, 25, 29) . Release of endotoxin (17, 27) by intestinal GNB and subsequent absorption of endotoxin by the intestinal mucosa (11, 16) may explain the relationship between intestinal GNB and myelopoiesis.
The nature of this relationship and significance to regeneration of myelopoiesis after cytotoxic reduction is under investigation.
